Note Activity of anti SARS CoV 2 specific monoclonal antibodies against currently circulating variants is significantly reduced tx w these agents is NOT recommended

By rray, 1 March, 2023

Detail (Long)

Note: Activity of anti–SARS-CoV-2-specific monoclonal antibodies against currently circulating variants is significantly reduced & tx w/ these agents is NOT recommended